Trial Profile
Randomized Comparison of the CHOlesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant patientS - The CHOLESS Trial
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Nutraceuticals
- Indications Hypercholesterolaemia
- Focus Adverse reactions
- Acronyms CHOLESS
- 15 Mar 2013 New trial record